» Articles » PMID: 25532487

A Simplified Method to Recover Urinary Vesicles for Clinical Applications, and Sample Banking

Overview
Journal Sci Rep
Specialty Science
Date 2014 Dec 24
PMID 25532487
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Urinary extracellular vesicles provide a novel source for valuable biomarkers for kidney and urogenital diseases: Current isolation protocols include laborious, sequential centrifugation steps which hampers their widespread research and clinical use. Furthermore, large individual urine sample volumes or sizable target cohorts are to be processed (e.g. for biobanking), the storage capacity is an additional problem. Thus, alternative methods are necessary to overcome such limitations. We have developed a practical vesicle isolation technique to yield easily manageable sample volumes in an exceptionally cost efficient way to facilitate their full utilization in less privileged environments and maximize the benefit of biobanking. Urinary vesicles were isolated by hydrostatic dialysis with minimal interference of soluble proteins or vesicle loss. Large volumes of urine were concentrated up to 1/100 of original volume and the dialysis step allowed equalization of urine physico-chemical characteristics. Vesicle fractions were found suitable to any applications, including RNA analysis. In the yield, our hydrostatic filtration dialysis system outperforms the conventional ultracentrifugation-based methods and the labour intensive and potentially hazardous step of ultracentrifugations are eliminated. Likewise, the need for trained laboratory personnel and heavy initial investment is avoided. Thus, our method qualifies as a method for laboratories working with urinary vesicles and biobanking.

Citing Articles

Sigma1 inhibitor suppression of adaptive immune resistance mechanisms mediated by cancer cell derived extracellular vesicles.

Castagnino P, Haas D, Musante L, Tancler N, Tran B, Kean R Cancer Biol Ther. 2025; 26(1):2455722.

PMID: 39863992 PMC: 11776462. DOI: 10.1080/15384047.2025.2455722.


Uromodulin and the study of urinary extracellular vesicles.

Harding M, Yavuz H, Gathmann A, Upson S, Swiatecka-Urban A, Erdbrugger U J Extracell Biol. 2024; 3(11):e70022.

PMID: 39582686 PMC: 11583080. DOI: 10.1002/jex2.70022.


Engineered extracellular vesicles for tissue repair and regeneration.

Zhang Y, Wu D, Zhou C, Bai M, Wan Y, Zheng Q Burns Trauma. 2024; 12:tkae062.

PMID: 39439545 PMC: 11495891. DOI: 10.1093/burnst/tkae062.


Utilizing engineered extracellular vesicles as delivery vectors in the management of ischemic stroke: a special outlook on mitochondrial delivery.

Chen J, Li Y, Quan X, Chen J, Han Y, Yang L Neural Regen Res. 2024; 20(8):2181-2198.

PMID: 39101653 PMC: 11759020. DOI: 10.4103/NRR.NRR-D-24-00243.


Natural killer cell-derived exosome-based cancer therapy: from biological roles to clinical significance and implications.

Si C, Gao J, Ma X Mol Cancer. 2024; 23(1):134.

PMID: 38951879 PMC: 11218398. DOI: 10.1186/s12943-024-02045-4.


References
1.
Eldh M, Lotvall J, Malmhall C, Ekstrom K . Importance of RNA isolation methods for analysis of exosomal RNA: evaluation of different methods. Mol Immunol. 2012; 50(4):278-86. DOI: 10.1016/j.molimm.2012.02.001. View

2.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

3.
Duijvesz D, Luider T, Bangma C, Jenster G . Exosomes as biomarker treasure chests for prostate cancer. Eur Urol. 2011; 59(5):823-31. DOI: 10.1016/j.eururo.2010.12.031. View

4.
Musante L, Saraswat M, Ravida A, Byrne B, Holthofer H . Recovery of urinary nanovesicles from ultracentrifugation supernatants. Nephrol Dial Transplant. 2012; 28(6):1425-33. DOI: 10.1093/ndt/gfs564. View

5.
Batagov A, Kurochkin I . Exosomes secreted by human cells transport largely mRNA fragments that are enriched in the 3'-untranslated regions. Biol Direct. 2013; 8:12. PMC: 3732077. DOI: 10.1186/1745-6150-8-12. View